🔎 Trials Near Me

Home › Head and Neck Squamous Cell Carcinoma › New York › Queens

Head and Neck Squamous Cell Carcinoma clinical trials in Queens, NY

20 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

RecruitingPhase 3
  • Northwell Health Physicians Partners Radiation Medicine at Queens, Forest Hills · 3 mi away
  • Queens Cancer Center, Rego Park · 3 mi away
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06992427

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

RecruitingPhase 3
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06589804

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

RecruitingPhase 3
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07276399

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

RecruitingPhase 2
  • NYU Langone Hospital - Long Island, Mineola · 11 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05136196

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

RecruitingPhase 1/2
  • START New York, Lake Success · 9 mi away
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07730021

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

RecruitingPhase 2
  • Perlmutter Cancer Center at NYU Langone Health, Mineola · 11 mi away
Ages 18 to 100 · All sexes · Updated Sep 15, 2026 · NCT05952934

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

RecruitingPhase 2
  • Long Island Jewish Medical Center, New Hyde Park · 9 mi away
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi away
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT02734537

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

RecruitingPhase 1
  • Site 107 - START New York - Long Island, Lake Success · 9 mi away
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07462377

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • START New York Long Island, Lake Success · 9 mi away
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07602842

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

RecruitingPhase 2/3
  • NYU Langone Hospital - Long Island, Mineola · 11 mi away
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT04333537

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

RecruitingPhase 1
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT05859074

A Study of MGC026 in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • START-New York Long Island, Lake Success · 9 mi away
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

RecruitingPhase 1/2
  • Clinical Research Alliance, Inc, Westbury · 14 mi away
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06330064

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

RecruitingPhase 1
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi away
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT04722523

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

RecruitingPhase 1
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · 9 mi away
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · 27 mi away
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT04389632

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

RecruitingPhase 1
  • START New York Long Island, LLC, Lake Success · 9 mi away
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07503808

A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma

RecruitingPhase 2
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Ages 18 and older · All sexes · Updated May 29, 2026 · NCT06485778

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

RecruitingPhase 3
  • Northwell Health Cancer Institute, Lake Success · 9 mi away
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT06064877

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

RecruitingPhase 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT07063212

Head and Neck Squamous Cell Carcinoma trials in other cities

Other studies in Queens

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.